AbbVie, Inc. (NYSE: ABBV) has delivered yet another quarter of strong top-line and earnings performance but issued cautious guidance for fiscal 2023
AbbVie sees near-term slowdown; looks prepared to tackle patent expiration
Categories
Health Care
Ventas Inc (VTR) Q4 2022 Earnings Call Transcript
Ventas Inc (NYSE: VTR) Q4 2022 earnings call dated Feb. 10, 2023 Corporate Participants: BJ Grant -- Senior Vice President-Investor Relations Debra A. Cafaro -- Chairman and
IQVIA Holdings Inc (IQV) Q4 2022 Earnings Call Transcript
IQVIA Holdings Inc (NYSE: IQV) Q4 2022 earnings call dated Feb. 10, 2023 Corporate Participants: Nick Childs -- Senior Vice President - Investor Relations and
Vertex Pharmaceuticals (VRTX) Earnings: 4Q22 Key Numbers
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported total revenues of $2.3 billion for the fourth quarter of 2022. This compares to $2 billion in
Veru Inc (VERU) Q1 2023 Earnings Call Transcript
Veru Inc (NASDAQ: VERU) Q1 2023 earnings call dated Feb. 09, 2023 Corporate Participants: Sam Fisch -- Executive Director, Investor Relations, and Corporate Communications Mitchell
AstraZeneca PLC (AZN) Q4 2022 Earnings Call Transcript
AstraZeneca PLC (NYSE: AZN) Q4 2022 earnings call dated Feb. 09, 2023 Corporate Participants: Andy Barnett -- Vice President Global Head of Investor Relations Pascal
Canopy Growth Corporation (WEED) Q3 2023 Earnings Call Transcript
Canopy Growth Corporation (TSE: WEED) Q3 2023 earnings call dated Feb. 09, 2023 Corporate Participants: Tyler Burns -- Director, Investor Relations David Klein -- Chief Executive
AbbVie (ABBV) Q4 2022 Earnings Call Transcript
AbbVie (NYSE: ABBV) Q4 2022 earnings call dated Feb. 09, 2023 Corporate Participants: Elizabeth Shea -- Vice President, Investor Relations Richard A. Gonzalez -- Chairman of
Humana AB (HUM) Q4 2022 Earnings Call Transcript
Humana AB (NYSE: HUM) Q4 2022 earnings call dated Feb. 09, 2023 Corporate Participants: Johanna Rastad -- Chief Executive Officer and President Fredrik Larsson -- Chief
AbbVie (ABBV) Q4 2022 Earnings: Key financials and quarterly highlights
AbbVie (NYSE: ABBV) reported fourth quarter 2022 earnings results today. Worldwide net revenues increased 1.6% year-over-year to $15.1 billion. Net earnings attributable
CVS Health Corporation (CVS) Q4 2022 Earnings Call Transcript
CVS Health Corporation (NYSE: CVS) Q4 2022 earnings call dated Feb. 08, 2023 Corporate Participants: Tom Kelly -- Senior Vice President of Capital Markets
CVS Earnings: CVS Health Q4 2022 profit, revenue increase
CVS Health Corporation (NYSE: CVS) on Wednesday announced financial results for the fourth quarter of 2022, reporting a modest increase in adjusted
Illumina Inc (ILMN) Q4 2022 Earnings Call Transcript
Illumina Inc (NASDAQ:ILMN) Q4 2022 Earnings Call dated Feb. 07, 2023. Corporate Participants: Salli Schwartz -- Vice-President of Investor Relations Francis deSouza -- President and Chief
Vertex Pharmaceuticals Incorporated (VRTX) Q4 2022 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q4 2022 earnings call dated Feb. 07, 2023 Corporate Participants: Susie Lisa -- Senior Vice President, Investor Relations Reshma
Centene Corporation (CNC) Q4 2022 Earnings Call Transcript
Centene Corporation (NYSE: CNC) Q4 2022 earnings call dated Feb. 07, 2023 Corporate Participants: Jennifer Gilligan -- Senior Vice President of Investor Relations Sarah
Cigna Corporation (CI) Q4 2022 Earnings Call Transcript
Cigna Corporation (NYSE: CI) Q4 2022 earnings call dated Feb. 03, 2023 Corporate Participants: Ralph Giacobbe -- Senior Vice President of Investor Relations David
Regeneron Pharmaceuticals Inc (REGN) Q4 2022 Earnings Call Transcript
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q4 2022 earnings call dated Feb. 03, 2023 Corporate Participants: Ryan Crowe -- Vice President, Investor Relations Leonard S.
CI Earnings: Highlights of Cigna Corp.’s Q4 2022 results
Cigna Corporation (NYSE: CI) has reported an increase in net income for the fourth quarter of 2022 when the healthcare services provider's
Infographic: Highlights of Gilead Sciences (GILD) Q4 2022 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) has reported a sharp increase in net profit for the fourth quarter of 2022 when
Earnings: Regeneron Pharmaceuticals (REGN) Q4 profit falls as revenues drop 31%
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Friday reported a sharp fall in fourth-quarter revenues and adjusted earnings. Total revenues plunged 31% year-over-year
Merck & Co Inc (MRK) Q4 2022 Earnings Call Transcript
Merck & Co Inc (NYSE:MRK) Q4 2022 Earnings Call dated Feb. 02, 2023. Corporate Participants: Peter Dannenbaum -- Vice President, Investor Relations Robert M.